Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient Revolution

crohnology data Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient RevolutionWhile speaking at FutureMed, Sean Ahrens explained his frustrations as a patient suffering from Crohn’s disease and his dissatisfaction with conventional treatments for the condition. To deal with the problem and to help others with Crohn’s or colitis, he created Crohnology, a patient-to-patient information sharing platform.

crohnology face Sean Ahrens at FutureMed: How Crohnology Is Fueling the Patient RevolutionAhrens explained how the platform fits into the broader context of the “patient revolution,” in which patients are becoming increasingly motivated to become active participants in their healthcare. This revolution is being fueled by mobile tools and social media, he said. And it is becoming necessary, as our healthcare system struggles to deal with rising cost pressures, an uptick in chronic conditions and as doctor–patient interaction becomes increasingly limited.

His Crohnology platform enables patients to share health and treatment information with each other, and to monitor the success of their treatments over time. This strategy enables patients to better deal with chronic conditions.

Many patients with chronic conditions such as Crohn’s have already turned into self experimenters. Ahrens himself fits into that mold, having intentionally infected himself with parasitic worms to see if they could help manage the disease. During his talk, he explained that he ordered a $3000 dose of the parasitic worms and created Crohnology, in part, to leave a “paper trail” to document the experiment.

Once the system was up and running, he used it to track his health over the course of an entire year and was able to gain a number of powerful insights from it. The system is even more powerful when it is opened up to a broader community of patients, he explained. “If we make better tools, we can make better conclusions.” The system can be used to collect many anecdotes from patients. After all, anecdotes are “data that we just haven’t scrubbed well yet,” he said.

Ahrens summarized his talk by saying: “The impact of these tools on health is going to be tantamount to the overthrow of media.”

Link: Crohnology…

FutureMed…

Medgadget Español

Medgadget Español

We’d like to remind our Spanish speaking readers to visit Medgadget Español, our project to make Medgadget content available to more people around the world. En Medgadget Español usted encontrará los mismos artículos de Medgadget, pero traducidos al español diariamente por profesionales, para el deleite de nuestra audiencia de habla hispana. Si tiene amistades, o conocidos que prefieran el idioma español y que tengan interés en las ciencias médicas, la tecnología y los dispositivos médicos, los descubrimientos científicos y la ingeniería biomédica, por favor riegue la voz y comparta con ellos nuestro enlace Medgadget.es.

Nuestra comunidad incluye a médicos y demás personal clínico, estudiantes de medicina, biología, ingeniería biomedica y ciencias generales, fabricantes de dispositivos médicos, administradores de hospitales, mediática de la salud, analistas de la salud y consumidores interesados.

Read More

Award-Winning Author Talks Personalized Medicine at FutureMed

Award-Winning Author Talks Personalized Medicine at FutureMed

Noted journalist and author David Ewing Duncan kicked off the Wednesday session of FutureMed by discussing personalized medicine and his work on the Experimental Man Project. The experiment, which is “ongoing,” is what Duncan described as a “humanized” way to look at personalized medicine, which can be useful in explaining the technology to the masses. He argued that personalized medicine stands in stark contrast to traditional medicine, which is “one-size-fits-all” and tries to fit patients “into a box.”

Pharmaceuticals are one of the most-needed applications of personalized medicine, he said, and the response rates for many drugs are pretty dismal. For instance, antidepressants don’t work for about 40% of people because they aren’t targeted for specific demographics based on genomic data. There is a low response rate to oncology drugs right now, Duncan added, but “we are getting better at targeting the drug to the right physiology.”

Read More

What’s Inside FutureMed’s Demo Room?

What's Inside FutureMed's Demo Room?

Singularity University’s FutureMed program is running this week. We’ll soon be covering segments of the event in more depth, but yesterday we peeked into their demo room to see what sort of medical technology advances they are showcasing.  Here is a sampling of what we found:

EyeNETRA grew out of a research effort at MIT’s Media Lab. They’ve developed a hardware sleeve that sits on top of a mobile phone, which, when paired with its corresponding software, enables the accurate diagnosis of refractive errors. Or said more simply, their system can check your eyes to see what prescription glasses you need.

Read More

Medgadget Q&A About VISIUS Surgical Theatre With Intra-Operative Imaging

Medgadget Q&A About VISIUS Surgical Theatre With Intra-Operative Imaging

Intra-operative imaging has been helping surgeons work on patients with greater confidence and increased precision.

We had a chance to ask Amy Boyle, Executive Vice President, Marketing at IMRIS, about the benefits of intra-operative imaging, and specifically about the company’s VISIUS Surgical Theatre that comes with either CT or MRI scanner that can quickly slide in and out of the OR to image the patient on the table as needed.

Read More

Medgadget Exclusive: Interview about the Healthbots

Medgadget Exclusive: Interview about the Healthbots

We are only two months into 2012 and it’s clear that the Quantified Self movement is increasingly gaining traction. More devices are emerging to help people quantify everything from anxiety to weight, and blood glucose to sleep patterns. But what about people who cannot use the devices or are not ambulatory themselves?

A team led by Professor Bruce MacDonald at the University of Auckland in New Zealand has been working to create a corp of medical robots – Healthbots – to help these people. Medgadget had the opportunity to interview Professor MacDonald about the Healthbots, what they do, and when we can expect to see them available to help those in need.

Read More

Interview with QuantiaMD, the Largest Online Network of Physicians

Interview with QuantiaMD, the Largest Online Network of Physicians

Given all of the recent media buzz surrounding Facebook – the Emperor of all Social Networks – we at Medgadget wanted to reflect some of that light onto the social networks that are most influencing medicine today. One such network is QuantiaMD, whose membership exceeds 150,000 physicians, according to the company, or one in five in the US!

We have previously covered two apps developed by the company: DiabetesIQ and Pri-Med. This editor first met up with QuantiaMD’s CEO, Eric Schultz, and Chief Communications Officer, Mary Modahl, at the mHealth Summit and just touched base again to produce the interview below.

Read More

Medgadget Exclusive: Interview with PathoGenetix and Sagentia about Rapid Microbial Detection Technology

Medgadget Exclusive: Interview with PathoGenetix and Sagentia about Rapid Microbial Detection Technology

Ever since the Danish bacteriologist Hans Christian Gram developed his eponymous test (the Gram stain) in 1882 to differentiate between types of bacteria, diagnostic tests have been integral to both public and individual health. The ability to rapidly and accurately detect microbes is becoming increasingly important given the emergence of diverse drug resistant strains, such as Methicillin-resistant Staphylococcus aureus (MRSA; Gram positive bacteria resembling purple grapes), as well as the length of time it currently takes to diagnose and treat certain infections (e.g. Mycobacterium tuberculosis, which cannot be detected via Gram stain but rather an acid-fast stain, has an incredibly slow doubling time which is why it can take weeks to accurately diagnose tuberculosis). In recent years genomic technologies have fortunately opened the doors for faster and more accurate detection of microbes than petri dish cultures and chemical staining can provide. Medgadget had the opportunity to interview two partner companies – PathoGenetix and Sagentia – that are developing a state-of-the-art Genome Sequence Scanning (GSS) technology, which promises to bring rapid microbial detection to the fields of microbial genomics research, food and product safety, and clinical infectious disease testing.

Shiv Gaglani, Medgadget: How many micro-organisms can be detected through the partnership technology?

Read More

Doctors in Tech: Interview with Medical Device Entrepreneur Kathy Stecco

Doctors in Tech: Interview with Medical Device Entrepreneur Kathy Stecco

Medgadget recently had the opportunity to interview Kathryn Stecco, MD, a globetrotting surgeon and an entrepreneur in the medical device space. Stecco is at once a medical consultant and monitor at BaroSense Inc., a surgical consultant at Mach Labs L.P., medical director of Nfocus Neuromedical Inc., and an external consultant to AKA Lifesciences. Dr. Stecco, who calls Silicon Valley home, has worked with local medical device legends Thomas Fogarty, MD and Mir Imran.

In this interview, she explains how studying medicine helped prepare her for working in the device field, and shares advice with physicians looking to follow a similar path to hers.

Read More